IMM 1.83% 41.8¢ immutep limited

Ann: First Clinical Data announced from 90mg Dosing of Efti, page-25

  1. 25,279 Posts.
    lightbulb Created with Sketch. 1365
    Another thing to consider is this study/trial was because of the FDA initiated project Optimus,
    which immutep through EFTI was approved to participate in, the FDA will be keen for their initiation
    to be a success, Immutep will be given all assistance in the future randomised trial....
    For those unaware the initial small trial whilst being most encouraging will draw some cyniscism from
    the market about being too small for a conclusive determination but also to the most cynical that those
    6 patients were targeted because they would be the most likely to return a positive result.....
    @coolkiat hit the nail on the head with the reference to the coming randomised trial which is approx
    one third filled at this stage...".Encouraging " is all the company can really say because the determing cohort
    was tiny but I betcha Frederic is very pleased with himself and for mine I expect him to be able to really
    puff his chest out a lot more in the not too distant future...
    Good day for us, make no mistake.....big tick this one...
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
41.8¢
Change
0.008(1.83%)
Mkt cap ! $598.3M
Open High Low Value Volume
41.0¢ 42.0¢ 41.0¢ $479.0K 1.158M

Buyers (Bids)

No. Vol. Price($)
6 270460 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 134826 22
View Market Depth
Last trade - 15.11pm 17/06/2024 (20 minute delay) ?
Last
42.0¢
  Change
0.008 ( 1.40 %)
Open High Low Volume
41.0¢ 42.0¢ 41.0¢ 372560
Last updated 15.25pm 17/06/2024 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.